Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation

NCT01094457 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.

NCT NCT01094457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01094457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation
Lead sponsor
Shenyang Northern Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2009
Completion date
June 30, 2012
Enrollment
840 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, clopidogrel low responsiveness, percutaneous coronary intervention